Clinical Trial Update: Oxaliplatin Combined With S-1(SOX) Neoadjuvant Chemotherapy for Different Cycles in Patients With Gastric Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating oxaliplatin with S-1 (SOX) as neoadjuvant chemotherapy for gastric cancer; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Oxaliplatin combined with S-1 (SOX) (oxaliplatin + S-1)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Gastric Cancer, Chemotherapy Effect | Phase 3 | Status: RECRUITING